Antibody Discovery News and Research

RSS
BioStreamline: Streamlining the development of next generation biotherapeutics

BioStreamline: Streamlining the development of next generation biotherapeutics

Sphere Fluidics closes $2 million USD (c. £1.5 million GBP) investment round

Sphere Fluidics closes $2 million USD (c. £1.5 million GBP) investment round

Sphere Fluidics collaborates with Peak Analysis and Automation to increase throughput in antibody discovery and cell line development

Sphere Fluidics collaborates with Peak Analysis and Automation to increase throughput in antibody discovery and cell line development

The Scientist names Cyto-Mine technology #1 in the Top 10 Innovations of 2018

The Scientist names Cyto-Mine technology #1 in the Top 10 Innovations of 2018

Oxford Genetics unveils OXGENE brand

Oxford Genetics unveils OXGENE brand

Rapid European adoption of Carterra’s LSA platform fuels expansion

Rapid European adoption of Carterra’s LSA platform fuels expansion

IONTAS and Teva Pharmaceuticals announce new antibody optimization agreement

IONTAS and Teva Pharmaceuticals announce new antibody optimization agreement

NIAID awards $22 million grant to develop antibody-based therapies against lethal viruses

NIAID awards $22 million grant to develop antibody-based therapies against lethal viruses

IONTAS wins 'Small Business of the Year' category at Cambridge News Business Excellence Awards 2019

IONTAS wins 'Small Business of the Year' category at Cambridge News Business Excellence Awards 2019

AvantGen and ACROBiosystems sign vendor agreement

AvantGen and ACROBiosystems sign vendor agreement

Sphere Fluidics announces closure of $2 million (circa £1.5 million) investment round

Sphere Fluidics announces closure of $2 million (circa £1.5 million) investment round

Sphere Fluidics and PAA collaborate to offer automated micro-plate handling capabilities for single cell analysis

Sphere Fluidics and PAA collaborate to offer automated micro-plate handling capabilities for single cell analysis

IONTAS founder and pioneer in phage display technology attends Nobel Prize Award Ceremony

IONTAS founder and pioneer in phage display technology attends Nobel Prize Award Ceremony

Integral Molecular and Merus collaborate to develop bispecific antibody therapeutics

Integral Molecular and Merus collaborate to develop bispecific antibody therapeutics

Vanderbilt researchers isolate antibody that can neutralize West Nile virus

Vanderbilt researchers isolate antibody that can neutralize West Nile virus

Antibody Screening Tools; Improving Workflows

Antibody Screening Tools; Improving Workflows

Harbour Biomed and Kelun-Biotech collaborate to develop, commercialize anti-PD-L1 antibody

Harbour Biomed and Kelun-Biotech collaborate to develop, commercialize anti-PD-L1 antibody

IONTAS collaborates with LG Chem to discover antibodies for treating cancer

IONTAS collaborates with LG Chem to discover antibodies for treating cancer

Oxford University Press and Chinese Antibody Society partner to launch Antibody Therapeutics

Oxford University Press and Chinese Antibody Society partner to launch Antibody Therapeutics

AbbVie and Voyager Therapeutics collaborate to develop new treatments for tauopathies

AbbVie and Voyager Therapeutics collaborate to develop new treatments for tauopathies